Aillis' AI Medical Device Wins Minister of Economy, Trade and Industry Award at 10th Monodzukuri Nippon Grand Award
Aillis wins Minister of Economy, Trade and Industry Award for its AI medical device nodoca.
📋 Article Processing Timeline
- 📰 Published: March 30, 2026 at 00:30
Aillis Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Sho Okiyama) has been awarded the Minister of Economy, Trade and Industry Award at the 10th Monodzukuri Nippon Grand Award in recognition of its efforts in "developing and promoting the AI medical device 'nodoca' to digitize pharyngeal examinations." The award ceremony was held at the Prime Minister's Office (Chiyoda-ku) on March 25.
The Monodzukuri Nippon Grand Award is a national recognition program that honors individuals and companies playing central roles in manufacturing and production, as well as those developing innovative products beyond conventional frameworks, in order to preserve and advance Japan's industrial and cultural heritage of "monodzukuri" (manufacturing craftsmanship). Aillis was highly recognized for developing a system that uses AI to determine infections from throat images and clinical information without requiring specimen collection, delivering it broadly to society, and building a "new value creation through data utilization" framework where data circulates to benefit patients and healthcare professionals. Medical data used in clinical practice through the AI medical device nodoca is processed in a privacy-compliant format under lawful and appropriate procedures, and is utilized to further improve pharyngeal AI algorithms for future clinical care.
The information and medical experiences obtained through this product are returned to clinical practice as a societal "resource," creating a cycle that benefits subsequent patients. The company will continue to promote the social implementation of cutting-edge technologies including AI, aiming to respond to evolving healthcare needs and build sustainable medical infrastructure.
■ About nodoca
nodoca® is an AI medical device that analyzes pharyngeal (throat) images and patient questionnaire information using AI, detecting findings characteristic of influenza to assist in influenza diagnosis. nodoca was developed with the involvement of over 100 domestic medical institutions. Additionally, it was developed through collaboration across "industry, government, academia, and medicine" in the fields of medical science and information engineering, including research and development as a "Japan Association for Acute Medicine Recommended AI Research," commercialization support from the New Energy and Industrial Technology Development Organization (NEDO), and utilization of the domestic supercomputer "ABCI" at the National Institute of Advanced Industrial Science and Technology (AIST).
■ About Aillis
Founded in 2017 with the mission of "Creating open medicine that everyone can co-create together." Led by CEO Okiyama, a practicing physician, the company brings together numerous professionals including healthcare workers, former officials from the Ministry of Health, Labour and Welfare and the Ministry of Economy, Trade and Industry, data scientists specializing in AI healthcare, and veterans from major medical device manufacturers, developing AI medical devices that digitize physicians' expert skills using deep learning technology (AI technology).
[Company Overview]
・Company name: Aillis Inc.
・CEO: Sho Okiyama
・Business: Development, manufacturing, and sales of AI-based medical devices, and research and development of machine learning technology
・Founded: November 2017
・Headquarters: 28-4 Kanda Higashimatsushita-cho, Chiyoda-ku, Tokyo 101-0042
・Corporate URL: https://aillis.jp/
The Monodzukuri Nippon Grand Award is a national recognition program that honors individuals and companies playing central roles in manufacturing and production, as well as those developing innovative products beyond conventional frameworks, in order to preserve and advance Japan's industrial and cultural heritage of "monodzukuri" (manufacturing craftsmanship). Aillis was highly recognized for developing a system that uses AI to determine infections from throat images and clinical information without requiring specimen collection, delivering it broadly to society, and building a "new value creation through data utilization" framework where data circulates to benefit patients and healthcare professionals. Medical data used in clinical practice through the AI medical device nodoca is processed in a privacy-compliant format under lawful and appropriate procedures, and is utilized to further improve pharyngeal AI algorithms for future clinical care.
The information and medical experiences obtained through this product are returned to clinical practice as a societal "resource," creating a cycle that benefits subsequent patients. The company will continue to promote the social implementation of cutting-edge technologies including AI, aiming to respond to evolving healthcare needs and build sustainable medical infrastructure.
■ About nodoca
nodoca® is an AI medical device that analyzes pharyngeal (throat) images and patient questionnaire information using AI, detecting findings characteristic of influenza to assist in influenza diagnosis. nodoca was developed with the involvement of over 100 domestic medical institutions. Additionally, it was developed through collaboration across "industry, government, academia, and medicine" in the fields of medical science and information engineering, including research and development as a "Japan Association for Acute Medicine Recommended AI Research," commercialization support from the New Energy and Industrial Technology Development Organization (NEDO), and utilization of the domestic supercomputer "ABCI" at the National Institute of Advanced Industrial Science and Technology (AIST).
■ About Aillis
Founded in 2017 with the mission of "Creating open medicine that everyone can co-create together." Led by CEO Okiyama, a practicing physician, the company brings together numerous professionals including healthcare workers, former officials from the Ministry of Health, Labour and Welfare and the Ministry of Economy, Trade and Industry, data scientists specializing in AI healthcare, and veterans from major medical device manufacturers, developing AI medical devices that digitize physicians' expert skills using deep learning technology (AI technology).
[Company Overview]
・Company name: Aillis Inc.
・CEO: Sho Okiyama
・Business: Development, manufacturing, and sales of AI-based medical devices, and research and development of machine learning technology
・Founded: November 2017
・Headquarters: 28-4 Kanda Higashimatsushita-cho, Chiyoda-ku, Tokyo 101-0042
・Corporate URL: https://aillis.jp/